BRIEF published on 08/08/2025 at 15:45, 3 months 27 days ago Lupus Alpha Asset Management Discloses Position in Alpha Group International Form 8.3 Takeover Code Securities Disclosure Lupus Alpha Alpha Group International
PRESS RELEASE published on 08/08/2025 at 15:40, 3 months 27 days ago Form 8.3 - Lupus alpha Asset Management AG: Alpha Group International plc Lupus alpha Asset Management AG discloses a 0.104% interest in Alpha Group International plc's 0.2p ordinary shares per Form 8.3 on 08-Aug-2025 Form 8.3 Disclosure Lupus Alpha Alpha Group International Plc Asset Management AG
BRIEF published on 06/26/2025 at 10:05, 5 months 8 days ago Lupus Alpha Asset Management AG Discloses Position in Alpha Group International plc Form 8.3 Takeover Code Shareholding Disclosure Lupus Alpha Alpha Group
PRESS RELEASE published on 06/26/2025 at 10:00, 5 months 8 days ago Form 8.3 - Lupus alpha Asset Management AG: Alpha Group International plc Lupus alpha Asset Management AG discloses 1.4481% stake in Alpha Group International plc as of 25th June 2025 Stake Disclosure Lupus Alpha Asset Management AG Alpha Group International Plc 1.4481% 25th June 2025
BRIEF published on 05/23/2025 at 11:45, 6 months 12 days ago Lupus Alpha Discloses Position in Alpha Group International Takeover Code Securities Disclosure Shareholding Lupus Alpha Alpha Group
PRESS RELEASE published on 05/23/2025 at 11:40, 6 months 12 days ago Form 8.3 - Lupus alpha Asset Management AG: Alpha Group International plc Lupus alpha Asset Management AG discloses a 1.24% stake in Alpha Group International plc as of 22.05.2025. No agreement or arrangement reported Disclosure Lupus Alpha Asset Management AG Alpha Group International Plc 1.24% Stake 22.05.2025
BRIEF published on 05/08/2025 at 12:35, 6 months 27 days ago Lupus Alpha Asset Management AG Discloses Position in Alpha Group International plc Securities Disclosure Takeover Code Lupus Alpha Alpha Group
PRESS RELEASE published on 05/08/2025 at 12:30, 6 months 27 days ago Form 8.3 - Lupus alpha Asset Management AG: Alpha Group International plc Lupus alpha Asset Management AG discloses a 1.247% interest in Alpha Group International plc shares. Form 8.3 filing details ownership positions Form 8.3 Share Disclosure Lupus Alpha Asset Management AG Ownership Positions Alpha Group International Plc
BRIEF published on 05/07/2025 at 14:50, 6 months 28 days ago Lupus Alpha Asset Management AG Discloses Position in Alpha Group International plc Takeover Code Securities Disclosure Share Purchase Lupus Alpha Asset Management AG Alpha Group International
PRESS RELEASE published on 05/07/2025 at 14:45, 6 months 28 days ago Form 8.3 - Lupus alpha Asset Management AG: Alpha Group International plc Lupus alpha Asset Management AG discloses 1.0974% stake in Alpha Group International plc according to Form 8.3. Details on positions and dealings provided Securities Form 8.3 Disclosure Lupus Alpha Asset Management AG Alpha Group International Plc
Published on 12/05/2025 at 02:35, 5 hours ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 35 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 30 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 35 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 35 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 5 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 44 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 10 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 20 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:00, 13 hours 35 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 50 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 51 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
